Zealand Pharma Feed

Land	Danmark
Lista	Mid Cap Copenhagen
Sektor	Hälsovård
Industri	Bioteknik

2020-09-22 14:17:42 Correction: Zealand Pharma announces amendments to its Articles of Association following the granting of warrants

2020-09-18 13:00:00 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants +0,69% | 27,6 MDKK

2020-09-14 16:13:52 Zealand Pharma grants warrants and restricted share units under the employee warrant program and management long-term incentive program +3,32% | 20,8 MDKK

2020-09-11 16:00:00 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants -0,09% | 16,9 MDKK

2020-09-04 12:00:00 Zealand Pharma builds Global Medical Affairs function with world-renowned experts -3,60% | 39,7 MDKK

2020-09-03 10:00:00 Zealand Pharma to participate in upcoming investor conferences -2,43% | 13,8 MDKK

2020-08-31 16:00:00 Total number of shares and voting rights in Zealand Pharma at August 31, 2020 +0,17% | 17,3 MDKK

2020-08-21 13:15:00 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants -0,59% | 24,9 MDKK

2020-08-13 15:00:00 Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application submission for the dasiglucagon HypoPal® rescue pen; pipeline progress including +5,01% | 36,6 MDKK

2020-08-06 10:00:00 Zealand Pharma hosts conference call on August 13 at 4 pm CET (10am ET) to present second quarter results for 2020 0,00% | 12,8 MDKK

2020-08-03 10:00:00 Zealand Pharma Continues to Build Investor Relations and Communications Function with the Appointment of Mads Kronborg +2,20% | 19,4 MDKK

2020-07-06 13:00:00 Zealand Pharma Expands U.S. Operations, Opens New Boston Office +0,17% | 24,4 MDKK

2020-06-30 18:00:00 Total number of shares and voting rights in Zealand Pharma at June 30, 2020 +0,97% | 23,2 MDKK

2020-06-24 08:55:00 Zealand Pharma announces first patient dosed in Phase 2 trial with long-acting GLP-1/glucagon dual agonist in obesity/diabetes -1,15% | 41,0 MDKK

2020-06-23 11:15:00 Zealand Pharma major shareholder announcement: Sunstone Life Science Ventures +0,25% | 41,5 MDKK

2020-06-22 11:15:00 Zealand Pharma completes registration of capital increase -0,33% | 47,4 MDKK

2020-06-18 00:25:00 Zealand Pharma announces completion of directed issue and private placement of 2,684,461 new ordinary shares -0,08% | 35,5 MDKK

2020-06-17 17:25:00 Zealand Pharma announces directed issues and private placements of up to approx. 2.68 million new ordinary shares -5,45% | 186 MDKK

2020-06-15 08:35:00 Zealand Pharma strengthens executive team with new U.S. leadership +1,12% | 36,3 MDKK

2020-06-14 17:00:00 Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association +1,12% | 36,3 MDKK

2020-06-13 17:00:00 Zealand Pharma presents elaborated results on the use of regular human insulin delivered by V-Go® in older adults with type 2 diabetes, at the 80th Scientific Sessions of the American Diabetes Association +1,12% | 36,3 MDKK

2020-06-12 11:00:00 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants -1,73% | 46,1 MDKK

2020-06-10 08:00:00 Zealand Pharma to leverage Intomics bioinformatics platform within peptide drug discovery and development process +1,26% | 34,9 MDKK

2020-06-01 21:55:48 Zealand Pharma to attend Jefferies and Goldman Sachs Virtual Healthcare Conferences -1,89% | 29,1 MDKK

2020-05-29 22:03:00 Total number of shares and voting rights in Zealand Pharma at May 31, 2020 -1,89% | 29,1 MDKK

2020-05-29 22:01:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons -1,89% | 29,1 MDKK

2020-05-26 11:45:00 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants +1,91% | 75,6 MDKK

2020-05-22 22:15:00 Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue pen for treatment of severe hypoglycemia +7,48% | 104 MDKK

2020-05-22 18:55:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +7,48% | 104 MDKK

2020-05-14 15:00:00 Zealand Pharma files New Drug Application with U.S. FDA for dasiglucagon HypoPal® rescue pen, secures DKK 137 million in additional investment, and accelerates readiness of U.S. commercial operations: Interim report for Q1 2020 -6,49% | 43,2 MDKK

2020-04-30 18:00:00 Total number of shares and voting rights in Zealand Pharma at April 30, 2020 -3,05% | 13,9 MDKK

2020-04-29 15:31:00 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants -1,55% | 33,5 MDKK

2020-04-27 16:30:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +1,43% | 40,6 MDKK

2020-04-20 20:39:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +1,84% | 53,5 MDKK

2020-04-20 20:36:47 Zealand Pharma hosts conference call on May 14 at 4 pm CEST (10 am EDT) to present first quarter results for 2020 +1,84% | 53,5 MDKK

2020-04-15 22:18:35 Zealand Pharma grants warrants and restricted stock units under the employee warrant program and management long-term incentive program +3,83% | 107 MDKK

2020-04-15 17:30:00 Zealand Pharma presents positive clinical and health economic outcome data with use of regular human insulin delivered by the V-Go in adults with type 2 diabetes +3,83% | 107 MDKK

2020-04-15 09:17:04 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants -4,55% | 54,4 MDKK

2020-04-08 12:17:38 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons -2,76% | 25,4 MDKK

2020-04-06 11:42:46 Zealand Pharma major shareholder announcement: Wellington Management Group LLP +5,16% | 46,7 MDKK

2020-04-03 11:57:07 Zealand Pharma’s Annual General Meeting 2020 -1,57% | 26,1 MDKK

2020-04-02 14:38:00 Zealand Pharma completes the acquisition of Valeritas -0,91% | 51,1 MDKK

2020-04-02 11:35:00 Zealand Pharma provides business update related to current COVID-19 situation -0,91% | 51,1 MDKK

2020-03-31 22:40:25 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons -6,42% | 55,4 MDKK

2020-03-31 18:00:00 Total number of shares and voting rights in Zealand Pharma at March 31, 2020 -6,42% | 55,4 MDKK

2020-03-31 15:45:18 Zealand Pharma submits New Drug Application to the U.S. Food and Drug Administration for the Dasiglucagon HypoPal® Rescue Pen for treatment of severe hypoglycemia +12,09% | 86,6 MDKK

2020-03-31 10:16:37 Zealand Pharma completes subscription of New Ordinary Shares and registration of capital increase +12,09% | 86,6 MDKK

2020-03-30 13:32:00 Zealand Pharma announces positive topline results from Phase 2 trial with dasiglucagon in individuals who have undergone bariatric surgery +6,98% | 71,7 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2020-11-12	Kvartalsrapport 2020-Q3
2020-08-13	Kvartalsrapport 2020-Q2
2020-05-14	Kvartalsrapport 2020-Q1
2020-04-03	Ordinarie utdelning ZEAL 0.00 DKK
2020-04-02	Årsstämma 2020
2020-03-12	Bokslutskommuniké 2019
2019-11-14	Kvartalsrapport 2019-Q3
2019-08-15	Kvartalsrapport 2019-Q2
2019-05-16	Kvartalsrapport 2019-Q1
2019-04-05	Ordinarie utdelning ZEAL 0.00 DKK
2019-04-04	Årsstämma 2019
2019-03-07	Bokslutskommuniké 2018
2018-11-15	Kvartalsrapport 2018-Q3
2018-08-16	Kvartalsrapport 2018-Q2
2018-05-16	Kvartalsrapport 2018-Q1
2018-04-20	Ordinarie utdelning ZEAL 0.00 DKK
2018-04-19	Årsstämma 2018
2018-03-07	Bokslutskommuniké 2017
2017-11-08	Kvartalsrapport 2017-Q3
2017-08-24	Kvartalsrapport 2017-Q2
2017-05-17	Kvartalsrapport 2017-Q1
2017-04-06	Ordinarie utdelning ZEAL 0.00 DKK
2017-04-05	Årsstämma 2017
2017-03-15	Bokslutskommuniké 2016
2016-11-09	Kvartalsrapport 2016-Q3
2016-08-25	Kvartalsrapport 2016-Q2
2016-05-18	Kvartalsrapport 2016-Q1
2016-04-20	Ordinarie utdelning ZEAL 0.00 DKK
2016-04-19	Årsstämma 2016
2016-03-16	Bokslutskommuniké 2015
2015-11-05	Kvartalsrapport 2015-Q3
2015-08-28	Kvartalsrapport 2015-Q2
2015-05-22	Kvartalsrapport 2015-Q1
2015-04-22	Ordinarie utdelning ZEAL 0.00 DKK
2015-04-21	Årsstämma 2015
2015-03-12	Bokslutskommuniké 2014
2014-03-21	Ordinarie utdelning ZEAL 0.00 DKK
2013-04-30	Ordinarie utdelning ZEAL 0.00 DKK
2012-04-26	Ordinarie utdelning ZEAL 0.00 DKK
2012-04-25	Årsstämma 2012
2011-04-29	Ordinarie utdelning

Zealand Pharma

Beskrivning

Kalender

Zealand Pharma

Beskrivning

Kalender

Språk

Typ

År

Språk

Typ

Ett Mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden